Research Calls
- Upgrades:
- Axsome Therapeutics (AXSM) upgraded to Neutral from Underperform at BofA Securities; tgt raised to $81
- DraftKings (DKNG) upgraded to Buy from Hold at Truist; tgt raised to $44
- NovoCure (NVCR) upgraded to Overweight from Neutral at Piper Sandler; tgt $45
- Quanterix (QTRX) upgraded to Outperform from Market Perform at SVB Securities; tgt $30
- Paymentus (PAY) upgraded to Neutral from Sell at Goldman; tgt raised to $12
- Tronox (TROX) upgraded to Neutral from Underperform at Credit Suisse; tgt raised to $13
- Smith & Nephew (SNN) upgraded to Neutral from Sell at UBS
- Vericel (VCEL) upgraded to Buy from Neutral at BTIG Research; tgt $39
- XPeng (XPEV) upgraded to Buy from Outperform at CLSA; tgt $24
- Downgrades:
- Alteryx (AYX) downgraded to Hold from Buy at Loop Capital; tgt lowered to $30
- Alteryx (AYX) downgraded to Neutral from Overweight at Piper Sandler; tgt lowered to $30
- Barclays PLC (BCS) downgraded to Neutral from Outperform at Exane BNP Paribas
- Chinook Therapeutics (KDNY) downgraded to Neutral from Outperform at Wedbush; tgt $42
- Douglas Emmett (DEI) downgraded to Underperform from Neutral at BofA Securities; tgt lowered to $10
- Enanta Pharmaceuticals (ENTA) downgraded to Hold from Buy at Jefferies; tgt lowered to $18
- FibroGen (FGEN) downgraded to Underperform from Neutral at BofA Securities; tgt lowered to $2
- Freshpet (FRPT) downgraded to Neutral from Overweight at JP Morgan; tgt raised to $84
- Inogen (INGN) downgraded to Neutral from Overweight at JP Morgan; tgt lowered to $8
- Intl Flavors (IFF) downgraded to Hold from Buy at Stifel; tgt lowered to $85
- Kilroy Realty (KRC) downgraded to Neutral from Buy at BofA Securities
- Maravai Life Sciences (MRVI) downgraded to Sector Weight from Overweight at KeyBanc Capital Markets
- National Storage Affiliates (NSA) downgraded to Hold from Buy at Stifel; tgt lowered to $35
- Proterra (PTRA) downgraded to Neutral from Buy at BTIG Research
- SAGE Therapeutics (SAGE) downgraded to Hold from Buy at Canaccord Genuity; tgt lowered to $21
- UWM Holdings (UWMC) downgraded to Mkt Perform from Mkt Outperform at JMP Securities
- Westlake Corporation (WLK) downgraded to Underweight from Neutral at JP Morgan; tgt raised to $123
- Willis Towers Watson (WTW) downgraded to Underperform from Market Perform at BMO Capital Markets; tgt lowered to $205
- WPP plc (WPP) downgraded to Hold from Buy at Deutsche Bank
- Others:
- APA Corp. (APA) placed on Positive Catalyst Watch at Citigroup; tgt raised to $52
- Apogee Therapeutics (APGE) initiated with a Buy at Guggenheim; tgt $29
- Apogee Therapeutics (APGE) initiated with a Buy at Jefferies; tgt $29
- Apogee Therapeutics (APGE) initiated with a Buy at Stifel; tgt $34
- Apogee Therapeutics (APGE) initiated with an Outperform at TD Cowen
- Apogee Therapeutics (APGE) initiated with an Outperform at Wedbush; tgt $40
- Exelixis (EXEL) initiated with a Market Perform at SVB Securities; tgt $18
- IDEAYA Biosciences (IDYA) initiated with an Outperform at SVB Securities; tgt $33
- Nuvalent (NUVL) initiated with a Market Perform at SVB Securities; tgt $42
- Sagimet Biosciences (SGMT) initiated with a Buy at Goldman; tgt $33
- Sagimet Biosciences (SGMT) initiated with a Mkt Outperform at JMP Securities; tgt $30
- Sagimet Biosciences (SGMT) initiated with an Outperform at TD Cowen
- Sagimet Biosciences (SGMT) initiated with an Overweight at Piper Sandler; tgt $67
- Spirit Airlines (SAVE) placed on 90-day downside catalyst watch at Citigroup
- Zealand Pharma (ZEAL) assumed with an Equal-Weight at Morgan Stanley